| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5325 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1337 | 2021 |
| Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche HS Dua, VA Shanmuganathan, AO Powell-Richards, PJ Tighe, A Joseph British Journal of Ophthalmology 89 (5), 529-532, 2005 | 488 | 2005 |
| The Arabidopsis MALE STERILITY1 (MS1) gene is a transcriptional regulator of male gametogenesis, with homology to the PHD‐finger family of transcription factors ZA Wilson, SM Morroll, J Dawson, R Swarup, PJ Tighe The Plant Journal 28 (1), 27-39, 2001 | 447 | 2001 |
| ELISA in the multiplex era: potentials and pitfalls PJ Tighe, RR Ryder, I Todd, LC Fairclough PROTEOMICS–Clinical Applications 9 (3-4), 406-422, 2015 | 441 | 2015 |
| Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy IA El-Ghrably, HS Dua, GM Orr, D Fischer, PJ Tighe British Journal of Ophthalmology 85 (4), 461-470, 2001 | 351 | 2001 |
| Antimicrobial defensin peptides of the human ocular surface RJ Haynes, PJ Tighe, HS Dua British journal of ophthalmology 83 (6), 737-741, 1999 | 229 | 1999 |
| The mannose receptor mediates the uptake of diverse native allergens by dendritic cells and determines allergen-induced T cell polarization through modulation of IDO activity PJ Royer, M Emara, C Yang, A Al-Ghouleh, P Tighe, N Jones, HF Sewell, ... The Journal of Immunology 185 (3), 1522-1531, 2010 | 215 | 2010 |
| Differential expression of TGF-β isoforms by normal and inflammatory bowel disease intestinal myofibroblasts BC McKaig, K Hughes, PJ Tighe, YR Mahida American Journal of Physiology-Cell Physiology 282 (1), C172-C182, 2002 | 195 | 2002 |
| Astrocytes as antigen‐presenting cells: expression of IL‐12/IL‐23 CS Constantinescu, M Tani, RM Ransohoff, M Wysocka, B Hilliard, ... Journal of neurochemistry 95 (2), 331-340, 2005 | 180 | 2005 |
| Guillain–Barré syndrome variant occurring after SARS‐CoV‐2 vaccination CM Allen, S Ramsamy, AW Tarr, PJ Tighe, WL Irving, R Tanasescu, ... Annals of neurology 90 (2), 315-318, 2021 | 163 | 2021 |
| Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-β content A Hopkinson, RS McIntosh, PJ Tighe, DK James, HS Dua Investigative ophthalmology & visual science 47 (10), 4316-4322, 2006 | 153 | 2006 |
| Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection AM Grabowska, F Lechner, P Klenerman, PJ Tighe, S Ryder, JK Ball, ... European journal of immunology 31 (8), 2388-2394, 2001 | 152 | 2001 |
| Treatment of Erdheim-Chester disease with cladribine: a rational approach C Myra, L Sloper, PJ Tighe, RS McIntosh, SE Stevens, RHS Gregson, ... British journal of ophthalmology 88 (6), 844-847, 2004 | 135 | 2004 |
| Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor–associated periodic syndrome indicates misfolding consistent … SL Rebelo, SE Bainbridge, MR Amel‐Kashipaz, PM Radford, RJ Powell, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 124 | 2006 |
| Effects of pro‐inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells L Jean‐Gilles, M Braitch, ML Latif, J Aram, AJ Fahey, LJ Edwards, ... Acta Physiologica 214 (1), 63-74, 2015 | 122 | 2015 |
| A thermoreversible hydrogel as a biosynthetic bandage for corneal wound repair C Pratoomsoot, H Tanioka, K Hori, S Kawasaki, S Kinoshita, PJ Tighe, ... Biomaterials 29 (3), 272-281, 2008 | 118 | 2008 |
| Mutant forms of tumour necrosis factor receptor I that occur in TNF‐receptor‐associated periodic syndrome retain signalling functions but show abnormal behaviour I Todd, PM Radford, KA Draper‐Morgan, R McIntosh, S Bainbridge, ... Immunology 113 (1), 65-79, 2004 | 117 | 2004 |
| Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A ML Nowlan, E Drewe, H Bulsara, N Esposito, RA Robins, PJ Tighe, ... Rheumatology 45 (1), 31-37, 2006 | 110 | 2006 |
| Role of interleukin‐6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin‐6 … PM Vaitla, PM Radford, PJ Tighe, RJ Powell, EM McDermott, I Todd, ... Arthritis & Rheumatism 63 (4), 1151-1155, 2011 | 100 | 2011 |
Ian ToddUniversity of NottinghamBestätigte E-Mail-Adresse bei nottingham.ac.uk
